The Role of inab in Axon Morphology of an Identified Zebrafish Motoneuron

The ability of an animal to move and to interact with its environment requires that motoneurons correctly innervate specific muscles. Although many genes that regulate motoneuron development have been identified, our understanding of motor axon branching remains incomplete. We used transcriptional expression profiling to identify potential candidate genes involved in development of zebrafish identified motoneurons. Here we focus on inab, an intermediate filament encoding gene dynamically expressed in a subset of motoneurons as well as in an identified interneuron. We show that inab is necessary for proper axon morphology of a specific motoneuron subtype.


Introduction
For correct locomotor circuitry to form in a developing embryo, motoneuron axons must contact appropriate muscle targets. Motoneurons are classified into subtypes that are based on their axon projections and morphologies, a hallmark of appropriate motoneuron subtype specification. Correct motoneuron development is mediated by expression of genes that allow motoneurons to acquire subtype-specific characteristics, such as axon morphology. Although a number of genes have been identified with necessary roles in motoneuron development, we still have an incomplete picture of the genes required for motoneuron differentiation and axon morphology.
The zebrafish spinal cord is an ideal model in which to study questions of early neuronal development, because there are a small number of individually identifiable neurons that can be observed in live animals over the course of development [1]. The earliestdeveloping motoneurons in the zebrafish spinal cord are referred to as primary motoneurons (PMNs); there are also later-developing motoneurons referred to as secondary motoneurons [2]. PMNs are especially amenable to study, because they have three distinct subtypes. Each of these subtypes projects an axon to a subtypespecific region in the overlying muscle [2,3] and expresses a number of genes differentially [4,5,6]. Not only can the mechanisms of PMN subtype specification be addressed genetically in zebrafish, but the genes known to be involved in zebrafish motoneuron specification are conserved across vertebrates.
To uncover additional genes involved in motoneuron development, including both differentiation and acquisition of axon morphology, we performed a microarray screen. By comparing the transcriptome of embryonic zebrafish spinal cords manipulated to have supernumerary motoneurons to that of spinal cords manipulated to have fewer motoneurons, we were able to select a number of candidate genes. These candidates were up-regulated or down-regulated in the same direction in each condition as genes already known to be expressed in zebrafish motoneurons. One of these candidate genes is internexin neuronal intermediate filament alpha b (inab) that encodes a neuronal intermediate filament. We chose to focus on this gene because of our interest in genes that potentially regulate motoneuron differentiation and axon morphology.
Neuronal intermediate filaments are a family of proteins thought to be involved in neuronal differentiation as well as acquisition of axonal morphology [7]. Upregulation of a number of neuronal intermediate filament proteins has been correlated with alterations in cellular morphology that accompany differentiation [8,9]. The genes that encode some intermediate filament proteins, such as nestin and ina, are expressed in mammalian neuroblasts at the end of migration and beginning of differentiation [10,11,12,13]. nestin is a well-characterized marker of neural progenitors [10,14] and both nestin and ina are thought to be involved in differentiation of neural progenitor cells and the accompanying acquisition of proper axonal morphology [7,9,15,16,17].
The goldfish and frog ina homologues are required for axon outgrowth and are upregulated in retinal ganglion cell axons after optic nerve crush [18,19,20]. Interestingly, different intermediate filament genes are expressed in different subpopulations of neurons as they acquire distinct morphologies [9], suggesting that intermediate filaments could be important for neuronal subtype specification.
In addition to its well-characterized role in the optic nerve, ina is expressed in spinal motoneurons of goldfish and frog, although its role in cells other than retinal ganglion cells has not yet been elucidated [18,21]. Zebrafish have two homologs of inainaa and inab -of which inab has been shown to be expressed in motoneurons [19,22]. Its presence there raises the possibility that it could be involved in aspects of motoneuron development.
Here we investigate which zebrafish PMN subtypes express inab. Zebrafish have three PMN subtypes, all derived from the progenitor of motoneuron (pMN) domain: CaP/VaP, MiP, and RoP [23]. CaP and VaP are initially equivalent MNs, referred to as CaP/VaPs, that go on to acquire distinct CaP and VaP fates [24,25,26,27]. CaP is present in all spinal hemisegments, and can be identified by a long, ventrally-extending axon. VaP is present in only approximately half of the spinal hemisegments, projects a short, ventrally-extending axon, and typically dies during embryonic development [24]. Both MiP and RoP are present in all spinal hemisegments. MiP can be identified by a dorsally-projecting axon, whereas RoP has a ventrally-projecting axon that arborizes more laterally than the CaP axon [2].
We also focus on an identified interneuron that arises from the pMN domain and can be a sibling to motoneurons, VeLD [23]. The VeLD cell body is located just dorsal to the PMNs [28]. VeLD can be identified by its ventral axon that descends ipsilaterally and projects caudally for many segment lengths [29,30].
We demonstrate that inab is expressed only in the CaP/VaP MN subtype. Surprisingly, VeLD interneurons also express inab. VeLDs and PMNs are derived from the same progenitor domain, can be siblings, and have been shown to express some of the same genes [6,23,31]. inab appears unnecessary for motoneuron or interneuron specification, but the axon morphology of VaP MNs is disrupted when inab is misspliced -VaP axons have an increased number of processes -however the number of processes on other PMN axons is not influenced by missplicing of inab. This work suggests that neuronal intermediate filament proteins are involved in acquisition of axon morphology and are often differentially expressed in neuronal subtypes.

Ethics statement
This study was carried out in strict accordance with the recommendations from the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the University of Oregon Institutional Animal Care and Use Committee (11)(12)(13)(14)(15)(16)(17)(18)(19)(20). All embryonic dissociations were performed under MS-222 anesthesia, and every effort was made to minimize suffering.

RNA synthesis and injections
Capped dominant negative rbpja (formerly Suppressor of Hairless) RNA was synthesized and injected as previously described [38]. This was sufficient to generate ectopic motoneurons as assayed by in situ hybridization with islet2a probe [31].
Full-length inab RNA was transcribed using the mMessage Machine kit (Ambion/Life Technologies, Grand Island, NY, USA) according to instructions. One-cell stage embryos were injected with 400 pg inab RNA for rescue experiments.

Spinal cord dissociations
Our embryonic dissociation protocol was adapted from one previously used in the lab [39]. Embryos were grown to 20 hpf and anesthetized using Finquel (MS-222) (Argent Laboratories, Redmond, WA, USA). To obtain isolated spinal cords, embryos were incubated in 7.56 pancreatin (MP Biomedicals, Irvine, CA, USA) in zebrafish physiological saline [36] until tissues began to separate (about 1 minute). Embryos were then triturated with Pasteur pipettes of decreasing size. Isolated spinal cords were transferred to Leibowitz's L15 medium (Gibco/Life Technologies, Grand Island, NY, USA) containing 10% fetal bovine serum for 1-2 minutes to inactivate the pancreatin, after which they were stored in TriReagent (Molecular Research Center, Inc., Cincinnati, OH, USA) at 280uC.

Microarray sample preparation
Isolated spinal cords in TriReagent were pooled and homogenized. RNA extraction was performed according to standard protocols [40]. The time investment required for tissue collection prohibited analysis of biological or technical replicates. However, all genes of interest were validated as described in the Results. Extracted RNA was amplified using a MessageAmp II aRNA kit (Ambien/Life Technologies, Grand Island, NY, USA) according to supplied instructions. Amplified RNA was shipped to Nimble-Gen (Roche NimbleGen Inc., Madison, WI, USA) where cDNA probes were synthesized and hybridized to Zebrafish Gene Expression 385K Arrays.

Microarray data analysis
Data analysis was carried out using ArrayStar software (DNASTAR Inc., Madison, WI, USA). Candidate genes were selected by relative transcript abundance across conditions and gene expression pattern criteria, and verified by RT-PCR and in situ hybridization.

Immunohistochemistry
Embryos were fixed overnight in 4% paraformaldehyde and 1x Fix Buffer at 4uC. Embryos were then blocked in 5% normal goat serum, 2.5% DMSO, and 0.1% Tween-20 in 16 PBS before overnight incubation in diluted primary antibody at 4uC. Unbound primary antibodies were removed by washing for 2 hours in 16 PBS plus 0.1% Tween-20, followed by overnight incubation in diluted secondary antibody at 4uC.
Antibodies used include monoclonal mouse anti-GFP 3E6

DNA Injections
To visualize individual neurons in the trunk, approximately 3 nL of 10 ng/mL UAS:EGFP CAAX :pA 395 plasmid (prepared using multisite Gateway technology [44]) was injected into 1 to 2-cell stage Tg(mnx1:GAL4) embryos. We selected embryos with GFPexpressing cells for immunohistochemistry.

Image acquisition
All images were acquired on a Zeiss Pascal confocal microscope (Carl Zeiss Microscopy, LLC, Thornwood, New York, USA) using either a 206 objective or a 406 water-immersion objective. The brightness and contrast of images was adjusted using Photoshop CS5 (Version 12.0, Adobe Systems, Inc., San Jose, CA, USA).

Image Quantification
All observations of PMNs were made in mid-trunk spinal cord adjacent to somites 8-12.
Image analysis was performed using a previously described pipeline [45]. First, we used the NeuronJ plugin [46] (NeuronJ: http://www.imagescience.org/meijering/software/neuronj/) for ImageJ (NIH, Bethesda, MD; ImageJ: http://rsb.info.nih.gov/ij/ ) to define the positions of neurites within raw confocal images. We used this neurite location data and the NeuronStudio software [47] (NeuronStudio: http://research.mssm.edu/cnic/tools-ns.html) to construct a connectivity diagram of each neuron, such that each branching neurite may only give rise to two daughter neurites. We examined these data, corresponding to the complete twodimensional arbor of each cell, using the MATLAB-based automated Sholl analysis program -Bonfire [45]. Sholl analysis produces a matrix of values corresponding to neurite length, number of branch points, and number of terminal points, as a function of radial distance from the soma. Images were scored blind, and resulting data were transferred to Excel for statistical analysis. Significance was determined using a two-tailed Student's T-test, with a p-value of less than 0.05 being considered significant. We also performed a noncentral t-distribution cumulative distribution function test which provides the minimum total sample size necessary to determine whether two samples are different from one another [48]. According to this test, a sample size of 10 provides a reliable measure for our data. We examined 14 VaPs, 11 CaPs with VaPs, 11 CaPs without VaPs, and 10 MiPs.

Expression profiling of zebrafish spinal cord using NimbleGen microarrays
We performed a microarray screen to uncover additional genes that are expressed in zebrafish PMNs and thus potentially involved in motoneuron development. For the screen, we compared spinal cords of embryonic zebrafish with supernumerary motoneurons to spinal cords with fewer motoneurons. To create embryos with more motoneurons than normal, we injected wild-type fish with mRNA encoding a dominant negative Rbpja protein (dnrbpja). This dominant negative protein interferes with Delta/Notch signaling in the embryo, thus creating supernumerary early-born neurons and increasing the number of PMNs [38]. On average, the number of islet2 + PMNs per hemisegment increases from 1-2 in control embryos to 3-6 in dnrbpja RNA-injected embryos [49]. To create embryos with fewer than normal motoneurons, we incrossed fish of the smoothened mutant line, smu b641 . The Smoothened protein plays a crucial role in Hedgehog signaling, which is required for normal motoneuron development [50]. Homozygous smu b641 mutants have disrupted Hedgehog signaling and consequently almost completely lack motoneurons, having on average 18 islet2 + PMNs per embryo [32,50].
To cut down on background from other tissues, we separated spinal cords from the rest of the tissues in the 20 hpf embryonic fish using our previous dissociation procedure [39]. After collecting a sufficient number of spinal cords (,200 per condition), we extracted RNA from each sample and amplified it. To confirm that spinal cords were present in each case, we used tissue-specific primers to verify presence of spinal cord genes and absence of contaminating hindbrain and muscle genes ( Figure S1). The amplified RNA was delivered to NimbleGen, where it was hybridized to microarrays.
We compared 10 genes known to be involved in motoneuron development -islet1, nkx6.1, nkx6.2, mnx1, mnx2b, met, scn8aa, dla, neurog1, and nfasca -and found that they were approximately 1.5 times upregulated in the supernumerary motoneuron condition as compared to uninjected, wild-type control embryos, as well as approximately 1.5 times downregulated in the decreased motoneuron condition as compared to wild-type control embryos. We then selected genes that were at least 1.5 times upregulated in the supernumerary motoneuron condition and 1.5 times downregulated in the decreased motoneuron condition, giving a list of 740 candidates.
We narrowed the list down by excluding ''housekeeping'' and hypothetical genes, giving a list of 101 candidate genes (Table S1). After excluding those genes expressed outside of the central nervous system and those initially expressed earlier than the birth of MNs or significantly after their maturation, we ended up with a list of 11 candidate genes (Table S1). To verify and further investigate expression patterns of the candidate genes, we obtained a clone of each gene from Open Biosystems and synthesized RNA probes for each of them. Here we provide information on three candidate genes that are expressed in ventral spinal cord.
One of the candidate genes, ccdc85al, is predicted to encode a transcription factor, and although it is expressed in the spinal cord, it is not expressed in PMNs and was therefore excluded from our analysis ( Figure S2). Another candidate, nr2f1b, is a transcription factor-encoding gene that is expressed in MNs, although it is also broadly expressed throughout the spinal cord ( Figure S2). Because its expression pattern is so broad, we excluded nr2f1b from our analysis as well. Here we describe expression and functional analysis of the third candidate gene, the intermediate filament-encoding gene inab, which we found to be expressed specifically in PMNs.

inab is dynamically expressed in a subset of primary motoneurons and in VeLD interneurons
We characterized expression of inab in the zebrafish spinal cord using RNA in situ hybridization. To determine whether PMNs express inab, we labeled embryos for islet1 mRNA, which all PMNs express before 14 hpf [31], and inab. In embryos older than 14 hpf, we labeled with probes for both islet1 mRNA (which after 14 hpf is expressed in PMN subtypes MiP and RoP) and inab, or islet2a mRNA (which after 14 hpf is expressed in PMN subtype CaP/ VaP) [31] and inab (Figure 2A-H). inab mRNA was not detected before 14 hpf. inab is expressed in CaP and VaP between 16 and 24 hpf (Figure 2F-H) and is subsequently downregulated in these cells. We never saw coexpression of inab and islet1, indicating that inab is not expressed in either MiP or RoP.
In addition to its expression in a subset of PMNs, inab is also expressed in cells that are more dorsal than the PMNs. To determine the identity of these cells, we labeled transgenic mnx1:GFP embryos with inab riboprobe. The mnx1:GFP transgene is expressed in all PMN subtypes and in VeLD interneurons (INs) before 24 hpf [6]. VeLD can also be identified by expression of the neurotransmitter GABA [6,51,52]. The inab + IN expresses both the mnx1 transgene and is labeled by an mRNA probe against gads, that encode the GABA synthetic enzymes, leading us to conclude that it is VeLD ( Figure 3I-J). inab expression in VeLD is initiated at 14 hpf and persists through 24 hpf.
inab is also expressed in a more dorsal, glutamatergic population of interneurons, with expression initiating around 18 hpf ( Figure 2K). Because we are interested in genes regulating motoneuron development, we excluded these neurons from our analysis.
There is a second zebrafish gene, called inaa, that is closely related to inab (http://zfin.org/action/marker/view/ZDB-GENE-060531-65). In the zebrafish genome, inaa is located on chromosome Dre13, whereas inab is found on chromosome Dre1. Teleost orthologs of inaa and inab are found on chromosomes Ola15 and Ola1 in medaka, on Tetraodon chromosomes Tni17 and Tni18, and in stickleback on chromosomes GacVI and GacIX, respectively. All these pairs of chromosomes contain chromosomal blocks duplicated during the course of the teleost genome duplication (TGD) derived from ancestral pre-TGC chromosome d. This strongly suggests that inaa and inab are paralogs of each other generated during the TGD as well [53,54]. We characterized expression of inaa using RNA in situ hybridization. We found that inaa is not expressed in the spinal cord between 14-24 hpf (Figure 3 A-D), and instead is expressed in only the diencephalon or adjacent to the diencephalic ventricle at 24 hpf ( Figure 3E). We therefore excluded inaa from our analysis.

inab is expressed in hybrid cells generated by mnx gene knockdown
We recently showed that in the absence of the three zebrafish Mnx homologs (Mnx1, Mnx2a, and Mnx2b), some MiP motoneurons become MiP-CaP hybrids that develop CaP-like axons [6]. MiPs do not normally express inab (Figure 2), but we hypothesized that some MiPs would express inab in the absence of Mnx proteins. To test this hypothesis, we injected previouslyvalidated [6], translation-blocking MOs against all three mnx genes into embryos of the Tg(nrp1a:GFP) line, in which MiPs weakly express GFP after 20 hpf. In MO-injected embryos, 32% of GFP + MiPs expressed inab (n = 16/50 MiPs, 10 embryos; Figure 4B), in contrast to 6% of GFP + MiPs in control embryos (n = 3/50 MiPs, 10 embryos; Figure 4A). This indicates that inab expression can be acquired by MiP-CaP hybrids that are generated in the absence of Mnx proteins, providing another molecular marker of CaP fate.

inab is required for proper morphology of VaP axons
To test the function of inab in PMN development, we used splice-blocking (SB) MOs to prevent proper splicing of inab mRNA. We designed MOs to target the exon 1/intron 1 boundary (SB1), the intron 1/exon 2 boundary (SB2), and the exon 2/intron 2 boundary (SB3) ( Figure 1A). Injection of up to 2 nL of either 900 mM SB1, 900 mM SB2, or 900 mM SB3 alone decreased the amount of correctly-spliced inab (data not shown). Only co-injection of 2 nL of 300 mM SB2 and 300 mM SB3 resulted in missplicing of all inab transcript ( Figure 1B inab is expressed in CaP, VaP and VeLD, so we hypothesized that its knockdown would have an effect on the axons of these particular cells. To assay any changes in axon morphology, we coinjected SB2 and SB3 MOs into nrp1a:GFP transgenic embryos, in which GFP is expressed exclusively in CaP/VaPs beginning at 18 hpf [33], and mnx1:GFP transgenic embryos, in which GFP is expressed in all PMNs and VeLD from 14 hpf on [6]. CaP/VaPs begin projecting axons ventrally around 16-17 hpf [2,3]. These axons are obvious by 20 hpf in both mnx1:GFP and nrp1a:GFP transgenic embryos [33,34,55]. VeLD also extends its   Figure S3A-B). However, the ventral motor nerve, which contains axons of both CaP and VaP MNs appeared to have more small processes than ventral motor nerves in control MO-injected embryos ( Figure S3A-B), suggesting a role for inab in axon branching or filopodia formation.
To learn which axons in the ventral nerve had extra processes, we injected UAS:EGFP plasmid into mnx1:GAL4 transgenic embryos, which allowed us to visualize individual CaP and VaP axons, and then used Bonfire analysis to examine the patterns of processes extending from individual CaP and VaP axons in control and MO-injected embryos. The Bonfire program uses spatial information about the position of neurites to quantify characteristics such as the number of branch points along the length of an axon, or the relative connectivity of the neurites [45]. We found no significant difference in the number of processes of CaP axons between control and MO-injected embryos, irrespective of whether CaP was adjacent to VaP ( Figure 5A-B, 5G). We also saw no difference in the number of processes along VeLD axons (data not shown). Another PMN, MiP does not express inab (data not shown), thus we used MiP as a control to examine specificity of the axon process phenotype of VaP. We saw no difference in processes along control and MO-injected MiP axons (data not shown). We did not examine RoP, another PMN that does not express inab (Figure 2), because RoP axons are often difficult to visualize until much later in development [2]. In contrast, VaP axons in inab MO-injected embryos had more processes than control VaP axons (n = 14, p = 0.02, Figure 5C-F, 5G), a phenotype that was rescued by coinjection of inab MO and fulllength inab mRNA (n = 13, p = 0.14). We also examined the localization of these supernumerary processes and determined that they were significantly different along the VaP axon shaft (p = 0.017), whereas there was not a significant difference along the VaP growth cone (p = 0.20).The small but significant difference in the number of processes along the VaP axon shaft indicates that while the overall morphology of ventral motor axons is unchanged by inab knockdown, process formation along the length of the VaP axon is increased. Surprisingly, injection of inab MOs has little other effect on VaP cell fate -VaPs in MO-injected embryos still typically died by 36 hpf as shown in previous studies of control VaPs [24,25] (data not shown).
These results demonstrate that the phenotype of inab knockdown is surprisingly specific to a single inab-positive primary motoneuron in the ventral spinal cord.

Discussion
Microarray candidate genes are expressed in the zebrafish spinal cord We used microarrays to identify genes that are expressed in zebrafish motoneurons and therefore potentially involved in motoneuron development. In our microarrays, we compared transcripts from spinal cords of embryos lacking Sonic hedgehog signaling to spinal cords from embryos lacking Notch signaling. We have previously shown that both of these signaling pathways  affect PMNs -excess PMNs are present in dnrbpj-injected embryos [38] and PMNs are decreased in smu mutant embryos [50]. However, both signaling pathways also affect other cell types in the ventral spinal cord [1]. Thus, although we specifically focused our attention on PMNs, some of the genes identified in our microarray may be expressed, and regulated similarly to PMN-specific genes, but in other ventral spinal cord cell types.
We identified three candidate genes that are expressed in the zebrafish ventral spinal cord. Here we show that one of these candidates, the predicted transcription factor-encoding gene ccdc85al, is expressed in a population of cells just dorsal to the PMNs. Although it is not expressed in motoneurons, it may be expressed in closely-related interneurons that are generated from the same progenitor domain as motoneurons in zebrafish [23]. Investigation of ccdc85al could potentially be interesting, because much remains to be learned about interneurons that are generated from the zebrafish pMN domain.
We also show that another candidate gene from the microarray, the transcription factor-encoding gene nr2f1b, is expressed broadly throughout the zebrafish spinal cord, including expression in PMNs. Based on its expression pattern, this gene may be less informative about mechanisms of motoneuron development than a gene with a cell type-specific expression pattern. The presence of nr2f1b in the spinal cord, however, merits further investigation.

Zebrafish have two ina paralogs
We show that the neuronal intermediate filament-encoding gene inab is expressed in a subset of zebrafish PMNs. In addition to inab, zebrafish also have another paralog of ina, named inaa, which we investigated alongside inab. We found that inaa is dynamically expressed in embryonic zebrafish, although not in PMNs during early development. This suggests that inaa and inab have diverged in function, leaving only inab with a role in PMN development.
inab is dynamically expressed in identified zebrafish spinal neurons We found that inab is expressed in a subset of zebrafish PMNs -CaP and VaP -and a closely-related interneuron -VeLD. Previous studies of genes involved in PMN specification have underscored a close relationship between specific PMN subtypes and corresponding classes of interneurons. For instance, MiP motoneurons seem to be closely-related to V2a interneurons; in the absence of either Nkx6 or Mnx proteins, MiPs form hybrids that have molecular and morphological characteristics of V2a interneurons [5,6]. On the other hand, CaP motoneurons and VeLD interneurons seem to be closely-related. In the absence of either Islet or Met proteins, CaPs form hybrids with molecular and morphological characteristics of VeLD interneurons [4,52]. Additionally, CaP and VeLD also arise from the same progenitor domain, and can even be siblings [23]. Therefore, the initial expression of inab in CaP/VaP and VeLD underscores the close relationship between these neurons.
We also demonstrated that inab is expressed in hybrid cells that have characteristics of both MiP and CaP motoneurons. We previously showed that in the combined absence of Mnx1, Mnx2a, and Mnx2b proteins, MiPs can acquire characteristics of both CaP motoneurons and V2a interneurons [6]. We were previously able to verify this MiP-CaP hybrid fate by only observing axon morphology, because there are few molecular markers that distinguish PMN subtypes. However, because we now know that inab is normally expressed in CaPs but not MiPs, we were able to use this marker to confirm that MiP-CaP hybrids co-express CaP markers as well as CaP morphology.
inab is required for correct VaP axon branching In addition to being expressed in such a specific subset of cells, the timing of inab expression also suggested that this gene may be involved in directed axon outgrowth or the acquisition of axon morphology. CaP, VaP and VeLD neurons begin extending axons around 16-17 hpf [2,3,28]. inab is first expressed in these cells at 16 hpf, around the time of axogenesis. inab expression is also maintained in CaP and VaP through 24 hpf, by which time the CaP axon has completed extension to the ventral aspect of the muscle segment [2]. The specific temporal expression of inab immediately before and during axogenesis in CaP, VaP and VeLD places it in the right position to be involved in the acquisition of axon morphology.
Indeed, we have shown that when inab is forcibly misspliced, VaP axons have significantly more processes than they do normally, indicating a role for inab in axon morphology of VaP MNs. The mechanism by which this axon morphology phenotype arises is unclear -inab may normally prevent VaP from reacting to some cue that promotes axon process formation. It is intriguing that although inab mRNA is expressed in CaP, VaP and VeLD, its disruption has an effect on only the VaP axon. It is unclear why this differential effect exists. inab may be interacting with as-yetunknown gene products specific to VaP MNs. We also do not know if there is differential expression of Inab protein. Although a working antibody against Inab does not currently exist, it would be interesting to learn whether Inab protein is differentially expressed in CaP and VaP. Regulation at the protein level could contribute to the differential effect of inab missplicing in these primary motoneurons.
Also worth noting is that although VaP axon morphology is changed when inab is disrupted, VaPs still typically die by 36 hpf, as they do in controls. This observation suggests that Inab is not involved in mediating VaP survival. This observation also indicates that the supernumerary processes of VaP axons are insufficient to overcome the normal interactions with CaP and muscle pioneer cells that are required to prevent VaP from extending a CaP-like axon and ultimately lead to VaP death [26,27].